117 related articles for article (PubMed ID: 26214640)
1. Kallikrein expression as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
Wu Y; Lu M; Zhou Q
J BUON; 2015; 20(3):855-61. PubMed ID: 26214640
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of vascular endothelial growth factor expression in women with ovarian cancer: A meta-analysis.
Hui G; Meng M
J BUON; 2015; 20(3):870-8. PubMed ID: 26214642
[TBL] [Abstract][Full Text] [Related]
4. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.
Xu K; Yang S; Zhao Y
Oncotarget; 2017 Jan; 8(1):285-302. PubMed ID: 27690218
[TBL] [Abstract][Full Text] [Related]
6. Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.
Shan W; Sun C; Zhou B; Guo E; Lu H; Xia M; Li K; Weng D; Lin X; Meng L; Ma D; Chen G
Oncotarget; 2016 Nov; 7(45):72672-72684. PubMed ID: 27682871
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
8. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Shan SJ; Scorilas A; Katsaros D; Rigault de la Longrais I; Massobrio M; Diamandis EP
Clin Chem; 2006 Oct; 52(10):1879-86. PubMed ID: 16916986
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.
Ma X; Bai J; Xie G; Liu Y; Shuai X; Tao K
PLoS One; 2017; 12(7):e0180173. PubMed ID: 28742860
[TBL] [Abstract][Full Text] [Related]
13. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
14. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion.
Li J; Li S; Chen R; Lu X
Oncotarget; 2017 Feb; 8(6):9672-9685. PubMed ID: 28039463
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.
Luo H; Li S; Zhao M; Sheng B; Zhu H; Zhu X
Oncotarget; 2017 May; 8(22):36845-36856. PubMed ID: 28415663
[TBL] [Abstract][Full Text] [Related]
18. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W
JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
Hoffman BR; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais IA; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis EP
Br J Cancer; 2002 Sep; 87(7):763-71. PubMed ID: 12232761
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]